Stem cell breakthroughs in UK: At a glance - Cord Blood News

Umbilical Cord Blood Stem Cells

Offers information about cord blood stem cells benefits and how to preserve your baby's umbilical cord blood through authorised cord blood banks.


Archive for April, 2009

Stem cell breakthroughs in UK: At a glance

April 28, 2009 By: admin Category: Cord Blood News Comments

It appears that as if British researcher are chasing the stem cell breakthroughs. At present British stem cell scientists are surely under the limelight of success, every now and then new news of stem cell breakthroughs and developments are showing up their faces to the world emerging from the British laboratories.

Britain being the first country in the world to introduce legislation to regulate and support the controversial embryonic stem cell research in 2002 have marched on very quickly and now there are more than 100 teams working on stem cell research in Britain.

Britain decided that human embryo research was highly valuable, so they allowed the research within a tight set of government regulations. Hence the science has flourished there for the last three decades. Other European countries like Germany and Italy have even more restrictions than the U.S.

Please find hereunder some of the main British success stories in stem cell breakthroughs.

At University College London : The worlds first stem cell therapy to cure the most common cause of blindness has been developed by British researchers using embryonic stem cells.

Researchers in university College London have been able to grow replacement cells to repair tissue destroyed by the most common cause of blindness, age-related macular degeneration. Prof Pete Coffey and Pfizer hope to begin clinical trials in patients within the year.

Another trial involving heart-attack patients is already under way. Emergency heart attack patients will be injected with their own stem cells in a dramatic new treatment. The procedure, being pioneered by British doctors, holds out hope of a cure as the stem cells repair damaged heart muscles.
Professor John Martin, who is leading the research, believes the stem cells can help repair some of the damage caused by heart attacks.

At University of Bristol: Famous stem cell scientist Professor Anthony Hollander who came into spot light after his team developed(in November) the first tissue- engineered windpipe(trachea) from patients own stem cell, once again is all set to create a stem cell bandage to avoid knee surgery.

Prof Hollander announced last week that he had established a new company, Azellon, to create cellular bandagesfrom patients bone-marrow stem cells which can be transplanted to repair torn knee cartilage. His colleague Dr Raimondo Ascione is also due to start work on another clinical trial using stem cells to repair damage caused during heart attacks.

At University of Edinburgh: Researcher of University of Edinburgh which is a major center of regenerative medicine, headed by renowned scientist Sir Ian Wilmut, announced on the end of last year that they had found a way to make an almost limitless supply of stem cells without using human embryos.

Following earlier work by Japanese scientists, they reprogrammed skin cells from adults, in effect winding the clock back so that they behaved like embryonic cells. The breakthrough promises to help overcome many of the ethical controversies involved in using embryonic stem cells. Researchers are also undertaking a major study into finding treatments for multiple sclerosis.

At Kings College London: UK scientists have found that stem cells can be used to cure stroke. This is one of the most exciting stem cell research.This a new technique to repair damage in the brain caused by strokes.

Dr Mike Modo, together with researchers at Nottingham University, found that stem cells implanted into the brains of rats formed new brain tissue and nerve connections.

Dr Mike Modo, of the team expressed his hope that they can offer the treatment to the patients within next 20 year.

At University of Sheffield: Dr Marcelo Rivolta last month announced that he could treat the damage to hair cells and neurons, deep inside the ear, that causes almost 90 per cent of hearing loss, by growing new cells and nerves.

The technique is being developed by scientists and doctors from University College London, Moorfields Eye Hospital, also in London, and Sheffield University, working together in the London Project to Cure Blindness.
Patients who have lost their sight in chemical accidents or through rare genetic diseases have had it partially restored thanks to a stem cell treatment developed by Dr Julie Daniels and her team. Using stem cells from tissue donors, they were able to grow new corneas in the laboratory for transplant.

Researches at the Manchester and Sheffield Universities have been able to identify the techniques to turn embryonic stem cells into insulin-producing pancreatic tissue. They will now be able to manipulate the stem cell to produce transcription factor, a protein necessary for treatment.

The team believes that the functional beta cells, if transplanted into the human body, can be a good solution for the type 2 diabetes. The cells produced by the team, resemble fetal pancreatic cells rather than adult tissue. The study, published in the Journal Public Library of Science, was funded by the Juvenile Diabetes Research Foundation and Medical Research Council.

At Cambridge University: The stem cell pioneer Professor Austin Smith and his team announced groundbreaking research (in February), that they had managed to reprogram adult mouse cells so that they behaved in a similar way to embryonic stem cells.

This approach had the added benefit that it did not involve the potentially harmful viruses used by other groups around the world to transfer the new genetic instructions to the patients cells.
The research was published in the journal Cell is the first of its kind that demonstrates germ-line transmission from rat ES cells. It makes use of a technology licensed exclusively to SCS by the University of Edinburgh and developed by Professor Austin Smith and his team, now at Cambridge University. the new technique would be generating consistently appropriate and stable at ES cells, which can be used to create genetically modified animals for medical, academic and pharmaceutical research.

At Newcastle University: Britain’s first human-animal hybrid embryos have been created last year, forming a crucial first step, scientists believe, towards a supply of stem cells that could be used to investigate debilitating and so far untreatable conditions such as Alzheimer’s disease, Parkinson’s and motor neurone disease.
Lyle Armstrong, who led the work, gained permission in January from the Human Fertilisation and Embryology Authority (HFEA) to create the embryos, known as “cytoplasmic hybrids”.

His team at Newcastle University produced the embryos by inserting human DNA from a skin cell into a hollowed-out cow egg. An electric shock then induced the hybrid embryo to grow. The embryo, 99.9% human and 0.1% other animal, grew for three days, until it had 32 cells.

Last year UK researchers have found that sperm cells can be turned into stem cells with similar properties to embryo stem cells. Thus the invention raises hopes of a ready supply of repair tissue for the body.
Scientists from Kings College in London used 22 separate samples from medical castrations and biopsies, and extracted sperm precursor cells (a form of adult stem cells with a fixed role) to become a sperm cell.The resulting cells were then chemically manipulated into a state similar to those in the embryo.

In another research stem cells from human bone marrow have been converted into early-stage sperm, claimed by the research team based at the North-east England Stem Cell Institute (NESCI), Newcastle.

The discovery will improve our understanding of natural sperm cell production and perhaps lead to novel fertility treatments in the long-term.

Source: Telegraph

Filed under Adult Stem Cell, Advocacy, Age-releted macular degeneration(AMD), Alzheimer’s Disease, Brain Disease, Ear, Embryonic Stem Cell, Eye, Heart, New study, Stem Cell, Stroke | Comment Below

Technorati Tags: , , , ,

Cord Blood Collection: What is the Process?

April 28, 2009 By: admin Category: Cord Blood Videos Comments

Cord Blood has already saved thousands of lives. It has been used successfully in the treatment of over 70 life-threatening diseases. See how simple and painless

Technorati Tags: , , , , , , , , , , , , , , , , , , , ,

Enhanced mesenchymal stem cell could improve tendonitis: Study reports

April 27, 2009 By: admin Category: Cord Blood News Comments

This new study was conducted by veterinarians from Cornell University on horses. It is quite evident that tendon injuries are a real problem for athletics as well as athletic horses. These type of injuries take longer time to heal and also boost the chances of future injuries.

The study evaluate the effect of mesenchymal stem cells, that was harvested from bone marrow is capable of transforming to tendon cells on tendon healing.

Researchers injected mesenchymal stem cells in horses with superficial digital flexor tendon (SDFT) injury. This stem cells were derived from the own bone marrow of those horses.

The ultrasound examinations of the tendons at 0, 2, 4, 6, and 8 weeks and mechanical, biochemical, and microscopic evaluation of the tendons 8 weeks after treatment was conducted by researchers.

According to lead researcher Alan J. Nixon, BVSc, MS, Dipl. ACVS, the biochemical composition of the treated and untreated tendons were similar 8 weeks after treatment.

However, tendons injected with the stem cells had significantly improved histology scores, indicating a more normal microscopic appearance in treated tendons than untreated tendons,

These results suggest that injecting mesenchymal stem cell directly into the damaged area of the SDFT is beneficial.

The study is scheduled to be published in an upcoming edition of the Journal of Orthopaedic Research.

Source: The Horse.com

Filed under Adult Stem Cell, New study, Sports Injury, Stem Cell | Comment Below

First ever pediatric stem cell transplantation done in Kolkata

April 27, 2009 By: admin Category: Cord Blood News Comments

Eight year old girl Pratima Aich from Dum Dum, Kolkata, who was suffering from neuroblastoma, a type of abdominal cancer, under went an autologus bone marrow stem cell transplantation at Kolkata.

Pratima’s cancer was detected on last year October. when her father took her at Mumbai for the treatment. She was advised for an urgent bone marrow stem cell transplantation as the cancer was in an advanced stage and the transplant is required to help recover the damaged bone marrow.

According to a city based paediatric haematologist, Dr Arpita Bhattacharyya, in paediatric cancers like neuroblastoma, very high doses of chemotherapy are required. Which destroys the bone marrow completely and threatens the life of the children.

Pratima’s stem cell transplantation was done on April 19 at Netaji Subhas Chandra Bose Cancer Research Institute in Park Lane, under the supervision of Dr Ashish Mukherjee and his team. The bone marrow was extracted from the pelvic bone, and stored at minus 80 degrees Celsius for a month and finally infused intravenously. The entire procedure costs about Rs. 6 lakhs. Patient will be kept in strict observation and treatment for another 3 months.

Though this is the first pediatric stem cell transplantation in the city, but doctors at NRS hospital in the month of February already have conducted a bone marrow transplantation on a blood cancer patient named Bela Samanta. Bela was 37 years old and and was suffering from multiple myeloma.

Source: The Telegraph

Filed under Adult Stem Cell, Cancer, Liver, Stem Cell | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Embryonic Stem cell technique to save eye got a major boost from Pfizer

April 27, 2009 By: admin Category: Cord Blood News Comments

Pharmaceutical giant Pfizer announced today that it will be funding clinical development of the UK stem cell research that shows promises to protect the eye from disease like age-related blindness and would also help to win permission from regulatory authorities to proceed the trials.

The new findings which is suppose to be one of the first successful applications originating from embryonic stem cells (ESC), would begin human trials within two years in UK.

Success of the eye patch created from embryonic stem cell is a unique proof that ESCs can indeed lead to valuable treatments, like prevention of blindness.

Pfizer will be taking forward the work in collaboration with Pete Coffey, the lead researcher of the team at University College London that has pioneered the work. Coffey and his team found the way to change the ESCs into retinal pigment epithelium (RPE) cells, which are highly required for perfect vision.

Coffey and his colleagues have already demonstrated that use of the RPE patches can save the sight of rats and pigs.

To avoid controversies researchers tried to build RPE patches from adult stem cells, but it is established that RPE patches made from embryonic stem cell’s are much more superior and effective than adult stem cells.

Source:NewScientist

Filed under Adult Stem Cell, Age-releted macular degeneration(AMD), Embryonic Stem Cell, Eye, New study, Stem Cell | Comment Below

Stem cell medicines will get a boost: claims UC San Diego Bioengineers

April 27, 2009 By: admin Category: Cord Blood News Comments

Lead researcher Kun Zhang, an assistant bioengineering professor in the UC San Diego Jacobs School of Engineering and his team at UC San Diego have developed a low cost accurate DNA methylation technique for researchers, that would be able to quantitatively analyze regenerative medicine as well as other diseases digitally using padlock probs.

The break through had been described in a in Nature Biotechnology titled Targeted bisulfite sequencing reveals changes in DNA methylation associated with nuclear reprogramming.

DNA methylation is a type of chemical modification of DNA that can be inherited and subsequently removed without changing the original DNA sequence.

Researchers used their novel method to study nuclear reprogramming of differentiated adult human cells into pluripotent stem cells.

Zhang and his team are using this new method to compare the use of artificial and natural stem cells.

This method will help determine whether artificial stem cells can 100 percent mimic natural stem cells. This method helps you determine if, by doing this trick, you can generate a stem cell similar to a natural stem cell. If it is not similar there may be some risk.

A key to the teams discovery was the use of programmable DNA chips made with a proprietary Ink-jet printing method by Agilent Technology.

Researchers believe that this is a generic method for the analysis of epigenome, the application to induced pluripotent stem cells is one example to demonstrate the utility of this method. The method would be widely applicable to other area of biomedical sciences, such as the study of cancers or Alzheimers disease.

Zhang and his team is looking forward to turn the clock forward and differentiate stem cells into multiple tissue and see how the memory of the cells changes.

They also wanted to compare the artificial stem cells with the natural stem cells to see whether the differentiation can work exactly the same efficiency on the artificial stem cells as they do on the natural stem cells.

Source: ScienceDaily

Filed under Adult Stem Cell, Alzheimer’s Disease, Cancer, New study, Stem Cell, induced pluripotent stem cell | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

Stem cells from fat tissue offer MS treatment hope

April 27, 2009 By: admin Category: Cord Blood News Comments

WASHINGTON – Stem cells derived from a patient’s own fat tissue can offer an effective treatment against multiple sclerosis (MS), say researchers from University of California San Diego.

The researchers demonstrated the possible effectiveness of stromal vascular fraction (SVF) cells in MS treatment.

“All three patients in our study showed dramatic improvement in their condition after the course of SVF therapy,” said lead researcher Dr. Boris Minev, from the Division of Neurosurgery, University of California San Diego.

“While obviously no conclusions in terms of therapeutic efficacy can be drawn from these reports, this first clinical use of fat stem cells for treatment of MS supports further investigations into this very simple and easily-implementable treatment methodology,” he added.

It is believed that SVF cells, and other stem cells, may be able to treat the condition by limiting the immune reaction and promoting the growth of new myelin sheath, which is often lost in MS.

“None of the presently available MS treatments selectively inhibit the immune attack against the nervous system, nor do they stimulate regeneration of previously damaged tissue. We’ve shown that SVF cells may fill this therapeutic gap,” said Minev.

First of the three patients, suffered frequent painful seizures for the previous three years, however after the treatment seizures had stopped completely and there were significant improvements in his cognition and a reduction of spasticity in his arms and legs.

The second patient reported improvements in his sense of balance and coordination, as well as an improved energy level and mood.

And the third one said his gait, balance and coordination improved dramatically over a period of several weeks.

The study appears in BioMed Central’s open access Journal of Translational Medicine. (ANI)

Filed under News | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

First ever stem cell education day celebrated at Maryland

April 27, 2009 By: admin Category: Cord Blood News Comments

Under graduate students highly interested in stem cell science and many of whom were looking forward to adhere stem cell technology as a career celebrates Stem Cell Education Day at the Maryland Science Center April 21,with leading stem cell researchers.

On the occasion leading stem cell researchers like, Curt Civin, MD, professor of pediatrics and director of the new Center for Stem Cell Biology and Regenerative Medicine at the School of Medicine, and Gary Fiskum, PhD, professor of anesthesiology at the School of Medicine, addressed the future of stem cell research for more than 50 undergraduate students.

Professor Civin is famous for discovering a way to isolate stem cells from other cells in the blood in 1984. He and Fiskum spoke on the future of stem cell research and what obstacles must be overcome before the promise of stem cells can be realized.

The free event was organized and sponsored by the Student Society for Stem Cell Research chapters at the University of Maryland, College Park and Johns Hopkins University.

Students have designed the event to help other undergraduates understand the potential of the field and how expanded funding will bolster career opportunities for aspiring doctors and scientists in the field.

The main person behind the entire effort is Josh Basile, a University of Maryland junior who suffered a spinal cord injury in a swimming accident at Bethany Beach, Del., in 2004. Josh, being a quadriplegic could feel the pain and obstacles, he believes, that stem cell research can help patients with devastating spinal cord injuries like his own.

Source: University of Maryland

Filed under Advocacy, Americas, Spinal Cord Injury, bone injury | Comment Below

Returning Hope hopes to offer stem cell treatment of blindness

April 27, 2009 By: admin Category: Cord Blood News Comments

Returning Hope, a pioneering Asian adult stem cell treatment portal, is expected to be one of the first in the world to offer the stem cell treatment for blindness. While very recently British scientists just have announced about the technique for curing macular-degeneration related blindness with adult stem cells.

Brian Dardzinski, CEO of Returning Hope, expects that Adult Stem Cell treatments for blindness will be available sooner in Thailand. He also confirmed that the treatment would be cheaper than others.

Returning Hope claimed that currently they offers autologous (derived from a patient’s own body) adult stem cell treatment for:

Some eye diseases

Neuromuscular degenerative diseases like Parkinson’s,
Alzheimers, Multiple Sclerosis, cerebral palsy and ALS

Injuries like spinal cord injury, stroke and brain injury

Diabetes, hair restoration, lung disease

While In Britain, elements of the technology have been tested in both rats and pigs In Asia, patients have already been helped regain their sight, claimed Returning Hope.

For further information you may contact
Brain Dardzinski, CEO
E-mail: bdardzinski ( @ ) returninghope dot com

Source: 1888pressrelease

Filed under Adult Stem Cell, Asia, Eye, Stem Cell | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,

‘Molecular key’ to successful blood stem cell transplants identified

April 27, 2009 By: admin Category: Cord Blood News Comments

WASHINGTON – Researchers at University of British Columbia have identified a ‘molecular key’ that has the potential to increase the success of blood stem cell transplants.

Blood stem cell transplants are currently used to treat diseases such as leukemia, Hodgkin’s lymphoma and aplastic anemia.

During the procedure, donor blood stem cells – which can produce red and white blood cells and platelets – are injected into the recipient to produce new blood.

The stem cells then need to travel to the thymus – an organ near the heart – and produce T-cells, a type of white blood cell that orchestrates the body’s immune system.

A common problem with blood stem cell transplants is the failure of stem cells to repopulate the thymus and generate T-cells. Without T-cells the patient is unable to fight infection and post-transplant prognosis is poor.

Now, Prof. Hermann Ziltener and his research team at UBC’s Biomedical Research Centre have identified a molecule called S1P that can tell the thymus to ‘open the gates’ and accept more stem cells.

“This discovery gives us a handle on determining whether the thymus will be receptive to migrating stem cells. By treating patients with drugs that control S1P, scientists can now manipulate the thymic gates to either open or close,” said Ziltener, a professor in the Dept. of Pathology and Laboratory Medicine.

The new study is published in the April issue of The Journal of Experimental Medicine. (ANI)

Filed under Cancer, News | Comment Below

Technorati Tags: , , , , , , , , , , , , , , , , , , ,


SEO Powered by Platinum SEO from Techblissonline